Evidence map›Paper›PMID 31133636›Full record

ArticleNature communications2019

Heterogeneous GM-CSF signaling in macrophages is associated with control of Mycobacterium tuberculosis.

Bryan D Bryson, Tracy R Rosebrock, Fikadu G Tafesse, Christopher Y Itoh, Armel Nibasumba, Gregory H Babunovic, Bjorn Corleis, Constance Martin, Caroline Keegan, Priscila Andrade and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
6.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. c-Myc inhibits macrophage antimycobacterial response inbioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Article
  11. Experimental dissection of tuberculosis protective immunity: a human perspective.Frontiers in cellular and infection microbiology · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Heterogeneity in lung macrophage control ofbioRxiv : the preprint server for biology · 2023
    Article
  19. Article
  20. iScience · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Bryan D BrysonHarvard T. H. Chan School of Public Health, 655 Huntington Avenue Boston, Boston, MA, 02115, USA.
Tracy R RosebrockHarvard T. H. Chan School of Public Health, 655 Huntington Avenue Boston, Boston, MA, 02115, USA.ORCID http://orcid.org/0000-0001-6339-6661
Fikadu G TafesseOregon Health and Science University, 3181 SW Sam Jackson Park Rd, Portland, OR, 97239, USA.
Christopher Y ItohHarvard T. H. Chan School of Public Health, 655 Huntington Avenue Boston, Boston, MA, 02115, USA.ORCID http://orcid.org/0000-0002-0721-4023
Armel NibasumbaHarvard T. H. Chan School of Public Health, 655 Huntington Avenue Boston, Boston, MA, 02115, USA.ORCID http://orcid.org/0000-0002-7108-1915
Gregory H BabunovicHarvard T. H. Chan School of Public Health, 655 Huntington Avenue Boston, Boston, MA, 02115, USA.ORCID http://orcid.org/0000-0003-4158-6979
Bjorn CorleisRagon Institute of MGH, MIT, and Harvard, 400 Technology Square Cambridge, Cambridge, MA, 02139, USA.ORCID http://orcid.org/0000-0001-9833-3169
Constance MartinHarvard T. H. Chan School of Public Health, 655 Huntington Avenue Boston, Boston, MA, 02115, USA.
Caroline KeeganDivision of Dermatology, David Geffen School of Medicine at University of California, California, USA.ORCID http://orcid.org/0000-0002-0852-5077
Priscila AndradeDivision of Dermatology, David Geffen School of Medicine at University of California, California, USA.
Susan RealegenoDivision of Dermatology, David Geffen School of Medicine at University of California, California, USA.
Douglas KwonRagon Institute of MGH, MIT, and Harvard, 400 Technology Square Cambridge, Cambridge, MA, 02139, USA.ORCID http://orcid.org/0000-0001-8521-8735
Robert L ModlinDivision of Dermatology, David Geffen School of Medicine at University of California, California, USA.ORCID http://orcid.org/0000-0003-4720-031X
Sarah M FortuneHarvard T. H. Chan School of Public Health, 655 Huntington Avenue Boston, Boston, MA, 02115, USA. sfortune@hsph.harvard.edu.ORCID http://orcid.org/0000-0001-7565-9975
Harvard University · USRagon Institute of MGH, MIT and Harvard · USOregon Health & Science University · US

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
Molecular Analysis of the Host Immune Response in LeprosyR01AI022553 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ROBERT L MODLIN · 1989 to 2026
$15.7M
TCR GAMMA/DELTA LYMPHOCYTES IN HUMAN SKIN LESIONSR01AR040312 · NIAMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MODLIN, ROBERT L · 1990 to 2025
$10.4M
Multidisciplinary HIV Training ProgramT32AI007387 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Daniel R. Kuritzkes · 1990 to 2026
$8.8M
IL-26 in host defense against infection by intracellular bacteria in skinR01AR073252 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MODLIN, ROBERT L · 2019 to 2023
$2.1M
Bacteriology PhD Training ProgramT32AI132120 · NIAID · HARVARD MEDICAL SCHOOL · PI RUDNER, DAVID Z · 2017 to 2021
$1.7M
Harvard University Center for AIDS Research (HU CFAR) AI060354NIAID NIH HHS P30 AI060354NIAID NIH HHS R01 AI022553NIAID NIH HHS T32 AI007387NIAID NIH HHS T32 AI132120NIAMS NIH HHS R01 AR040312NIAMS NIH HHS R01 AR073252U.S. Department of Health & Human Services | National Institutes of Health (NIH) T32AI132120
6 · The paper itself

Abstract

Variability in bacterial sterilization is a key feature of Mycobacterium tuberculosis (Mtb) disease. In a population of human macrophages, there are macrophages that restrict Mtb growth and those that do not. However, the sources of heterogeneity in macrophage state during Mtb infection are poorly understood. Here, we perform RNAseq on restrictive and permissive macrophages and reveal that the expression of genes involved in GM-CSF signaling discriminates between the two subpopulations. We demonstrate that blocking GM-CSF makes macrophages more permissive of Mtb growth while addition of GM-CSF increases bacterial control. In parallel, we find that the loss of bacterial control that occurs in HIV-Mtb coinfected macrophages correlates with reduced GM-CSF secretion. Treatment of coinfected cells with GM-CSF restores bacterial control. Thus, we leverage the natural variation in macrophage control of Mtb to identify a critical cytokine response for regulating Mtb survival and identify components of the antimicrobial response induced by GM-CSF.

Indexed as

Blood Buffy CoatCells, CulturedGene Expression ProfilingGranulocyte-Macrophage Colony-Stimulating FactorHIVHIV InfectionsHumansInterferon-gammaMacrophagesMycobacterium tuberculosisPrimary Cell CultureSequence Analysis, RNASignal TransductionTuberculosisVitamin DCSF2 protein, humanGranulocyte-Macrophage Colony-Stimulating FactorInterferon-gammaVitamin D

Identifiers

PMID31133636
PMCPMC6536549
OpenAlexW2947753150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.